Safety and Effectiveness of Autologous Adipose Tissue Derived Mesenchymal Stem Cell Implantation in Patients With CP
NCT ID: NCT03979898
Last Updated: 2019-06-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
EARLY_PHASE1
1 participants
INTERVENTIONAL
2017-06-15
2019-05-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neuroregenerative Potential of Intravenous G-CSF and Autologous Peripheral Blood Stem Cells
NCT02983708
Mechanism of Allogeneic UCB Therapy in Cerebral Palsy
NCT03130816
Efficacy of Stem Cell Transplantation Compared to Rehabilitation Treatment of Patients With Cerebral Paralysis
NCT01929434
Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Intravenous Infusion for CP
NCT05018871
Neural Stem Cells Therapy for Cerebral Palsy
NCT03005249
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Astrostem
Autologous Adipose Tissue Derived Mesenchymal Stem Cells
ASTROSTEM
Intravenous injection of Autologous Adipose derived mesenchymal stem cells. Dose : 15kg below : 0.5x10\^7cells/5mL 15kg \~ 25kg : 1x10\^8cells/10mL 25kg over : 1.5x10\^8cells/15mL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ASTROSTEM
Intravenous injection of Autologous Adipose derived mesenchymal stem cells. Dose : 15kg below : 0.5x10\^7cells/5mL 15kg \~ 25kg : 1x10\^8cells/10mL 25kg over : 1.5x10\^8cells/15mL
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age : 36 months - 12 year, males and females
* Subjects who understand and sign the consent form for this study
* Kaufman Assessment Battery for Children 50\<K-ABC\<100
Exclusion Criteria
* Genetic Diseases
* Recent cancer patients within 1 year
* patients witn a psychiatric disorder that may interfere in the clinical trial
* participating another clinical trials within 3 months
* Recently there is a change of the abrupt symptoms within three months of the patient
* Subjects with a infectious disease include HIV and VDRL
* Patients who penicillin hypersensitivity reactions
* Other pathologic conditions or circumstances that difficult participation in the study according to medical criteria
36 Months
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kyung Hee University Hospital at Gangdong
OTHER
R-Bio
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
KyungHee University Gandong Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
biostar-CP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.